期刊文献+

糖皮质激素诱导肾虚骨质疏松症大鼠骨组织中PPARγ2的mRNA及蛋白表达的影响 被引量:4

Experimental Studies on Expressions of PPARγ2 mRNA and Protein of Bone Tissue in Kidney Deficient Rats with Osteoporosis Induced by Glucocorticoid
下载PDF
导出
摘要 目的:研究糖皮质激素骨质疏松症大鼠骨组织中PPARγ2的mRNA和蛋白表达,揭示糖皮质激素骨质疏松症的发病机理,阐述纳米钙补肾中药的调节作用机制。方法:用糖皮质激素注射的方法复制骨质疏松症模型,用纳米钙及具有益肾填精、补钙壮骨作用的补肾中药高、低剂量对实验大鼠治疗8周,以骨疏康颗粒、盖天力钙片作为阳性对照组,正常大鼠和模型空白组为空白对照组。用PCR法、Western印迹法检测骨质疏松症大鼠骨组织中PPARγ2的mRNA和蛋白表达。结果:正常大鼠骨组织可以在基因、蛋白水平表达PPARγ2,而且在骨髓脂肪细胞分化中可能起到重要的作用,糖皮质激素对大鼠骨质疏松症的发生与骨组织中PPARγ2 mRNA和蛋白表达的变化有关,从而影响骨髓脂肪细胞形成。结论:纳米钙补肾中药通过调控大鼠骨组织中PPARγ2 mRNA和蛋白表达,抑制骨髓脂肪细胞的形成,从而对糖皮质激素性骨质疏松症有一定的防治作用。 Objective : To study expressions of PPARγ2 mRNA and protein of the bone tissue in kidney rats with oste- oporosis induced by glucocorticoid. To reveal the pathogenesis of glucocorticoids osteoporosis. To explore to the mechanism of the adjustable function of nanometer calcium kidney - tonifying Chinese herbs. Methods : Using the method of glu- cocorticoid injection,we established the rat model of osteoporosis due to kidney - deficiency. The osteoporosis rats with experimental drugs (high,low dose group) were treated for $ weeks, which were notifying kidney to consolidate the essence and strengthening bone and marrow, invigorating the kidney to make the bone strong. Simultaneously, Gushukang granule and Gaitianli tablets were used as positive control groups. And rats in the normal group and model group were not given any treatment. We used the PCR method and Western blotting method to detect the expression of PPARγ2 mRNA and proteins in the bone of the rats. Results : Normal rat bone tissue can be the expression of PPARγ2 mRNA in gene and protein level,which was important for bone marrow cells differentiation. The occurrence of osteoporosis was related to the change of bone tissue PPARγ2 mRNA and the protein expression, and thus it can affect bone marrow fat ceils formation. Conclusions : Nanometer calcium kidney - tonifying Chinese herbs can control rat bone tissue of PPARγ2 mRNA and protein expression and inhibit the formation of bone marrow fat cells, and thus prevent and control the osteoporosis
机构地区 辽宁中医药大学
出处 《中华中医药学刊》 CAS 2014年第1期25-27,共3页 Chinese Archives of Traditional Chinese Medicine
基金 国家自然科学青年基金项目(81302879) 辽宁省博士启动基金项目(20101068)
关键词 糖皮质激素 骨质疏松症 纳米钙补肾中药 PPARΓ2 glucocorticoid osteoporosis nanometer calcium compound kidney invigorating Chinese herbs PPARγ2
  • 相关文献

参考文献3

二级参考文献49

  • 1谢华,李青南,黄连芳,吴铁.蛇床子总香豆素对类固醇性骨质疏松的作用[J].中国药理学报,1994,15(4):371-374. 被引量:52
  • 2吴铁,崔燎,陈志东,张志平,廖进民,李青南,黄连芳.壮骨肾宝对抗泼尼松不良反应的实验研究[J].中国中医药科技,1996,3(4):16-19. 被引量:16
  • 3吴铁,崔燎,张志平,陈志东,李青南,廖进民,黄连芳.淫羊藿对抗肾上腺皮质激素不良反应的实验研究[J].中国中药杂志,1996,21(12):748-751. 被引量:37
  • 4Dlany AM, Jerffrey JJ, Rydziel S, et al. Cortisol increases intertitial collagenase expression in osteoblasts by post-transcriptional mechanisms[ J]. J Biol Chem, 1995, 270:26607- 26612. 被引量:1
  • 5Mundy G, Garrett R, Harris S, et al. Stimulation of bone formation in vitro and in rodents by statins[J]. Science, 1999, 286:1946-1949. 被引量:1
  • 6Chan KA, Andrad SE, Boles M, et al. Inhibitors of hydroxymethylglutary-coenzyme A reductase and risk of hip fracture among old women[J]. Lancet, 2000,355:2185 - 2188. 被引量:1
  • 7Wang P, Solomon DH, Hogun H, et al. HMH - CoA reductase inhibitors and the risk of hip fractures in elderly patients[J]. JAMA,2000, 283:3211-3216. 被引量:1
  • 8Chung YS, Lee MD, Lee SK, et al. HMG-CoA rediuctase inhibitors increase BMD in type2 diaberes mellitus patients[J]. J Clin Endocrinol Metab, 2000, 85:1137 - 1142. 被引量:1
  • 9Jeffrey M, Gimble E, Katherine A, et al. Peroxisome proliferatoractivated receptor - gamma activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells[J]. Mol Pharmacol, 1996,50:1087 - 1094. 被引量:1
  • 10Xing MS, Harry C, Blair M, et al. Tandem repeat of C/EBP binding sites mediates PPAR-gamma2 gene transcription in glucocortixcoid-induced adipocyte differentiation[J]. J Cell Biochem, 2000,76: 518-527. 被引量:1

共引文献15

同被引文献118

  • 1汤群芳,孔令军,顾振纶,谢梅林.蛇床子素抑制大鼠骨质疏松的实验研究[J].中草药,2006,37(11):1700-1702. 被引量:24
  • 2史传道,汶勇军,贾文鹏,段永峰.抗疏健骨颗粒对糖皮质激素骨质疏松大鼠骨密度和血清IL-6的影响[J].陕西中医学院学报,2007,30(5):63-65. 被引量:13
  • 3Khan MP, Mishra JS, Sharan K, et al. A novel flavonoid C- glucoside from Ulmus wallichiana preserves bone mineral density, microarchitecture and biomechanical properties in the presence of glucocorticoid by promoting osteoblast survival: a comparative study with human parathyroid hormone [ J ]. Phytomedicine, 2013,20 ( 14 ) : 1256-1266. 被引量:1
  • 4Lucinda LM, Aarestrup B J, Brandao JS, et al. The effect of Ginkgo biloba extract treatment in the Bcl-2 expression by osteoblasts in the femoral trabecular bone of Wistar rats with glucocorticoid-induced osteoporosis [ J ]. Revista brasileira de Farmacognosia,2014,24(3) :363-366. 被引量:1
  • 5Kim J, Lee H, Kang KS, et al. Protective effect of Korean Red Ginseng against glucocorticoid-induced osteoporosis in virto and in vivo [ J ]. Journal of Ginseng Research, 2015,39( 1 ) :46-53. 被引量:1
  • 6Suhana MR, Farihah HS, Faizah O, et al. Piper sarmentosum prevents glucocorticoid-induced osteoporotic bone resorption by increasing 11 beta-hydroxysteroid dehydrogenase type 1 activity [ J ]. Clin Ter, 2011,162 (4) :313-318. 被引量:1
  • 7Ramli ES, Suhaimi F Asri SF, et al. Glycyrrhizic acid (GCA) as l ll3-hydroxysteroid dehydrogenase inhibitor exerts protective effect against glucocorticoid-induced osteoporosis [ J ]. Journal of Bone and Mineral Metabolism, 2013,31 ( 3 ), 262 -273. 被引量:1
  • 8Cheng BB, Li J, Du J, et al. Ginsenoside Rbl inhibits osteoclastogenesis by modulating NF-KB and MAPKs pathways[ J ]. Food and Chemical Toxicology, 2012, 50 (5) :1610-1615. 被引量:1
  • 9Dai WW, Jiang L, Lay YAE, et al. Prevention glucocorticoid induced bone changes with beta-ecdysone [ J]. Bone,2015,7:48-57. 被引量:1
  • 10冀亮.滋肾丸对糖皮质激素性骨质疏松大鼠骨代谢的改善作用及机制研究[D].成都:成都中医药大学,2011. 被引量:1

引证文献4

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部